HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monoclonal antibody-defined antigen of human uterine endometrial carcinomas is Leb.

Abstract
A monoclonal antibody, MSN-1, generated by immunizing a mouse with a human uterine endometrial adenocarcinoma cell line, SNG-II, was strongly and specifically reactive with neutral glycosphingolipids from cancer tissues of patients with uterine endometrial adenocarcinomas. The glycosphingolipid antigen was purified from pooled human meconia, which contained the antigen at the concentration of 1.95 mumol/g dry weight. Its structure was determined by NMR, negative ion FABMS, permethylation analysis, and TLC-immunostaining with monoclonal anti-Lc4Cer antibody, and was concluded to be the III4IV2Fuc2Lc4Cer,Leb antigen of the human Lewis blood system. On ELISA, the monoclonal antibody was found to be strongly reactive with Leb, slightly with Lea and not at all with A, B, H, or IV2FucGg4Cer. The amount of Leb in cancerous regions in the patients with the Lea-b+ blood group was significantly increased compared to that in normal regions in the same patients, and it was a newly appearing antigen in the cancerous tissue of a patient with the Lea+b- blood group.
AuthorsM Iwamori, M Sakayori, S Nozawa, T Yamamoto, M Yago, M Noguchi, Y Nagai
JournalJournal of biochemistry (J Biochem) Vol. 105 Issue 5 Pg. 718-22 (May 1989) ISSN: 0021-924X [Print] England
PMID2753871 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Glycosphingolipids
  • Lewis Blood Group Antigens
Topics
  • Adenocarcinoma (blood, immunology)
  • Animals
  • Antibodies, Monoclonal
  • Antigens, Neoplasm (analysis)
  • Chromatography, Thin Layer
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Glycosphingolipids (immunology)
  • Humans
  • Hydrolysis
  • Lewis Blood Group Antigens (immunology)
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Uterine Neoplasms (blood, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: